Belderm SRL
Belderm reported total assets of 7,299 € at the end of the 2025 financial year (annual accounts filed with the NBB on 07 Aug 2026).
The score of Belderm shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +81 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Belderm's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 07 Aug 2026
- Year ended 31 Dec 2024filed on 10 Jul 2025
- Year ended 31 Dec 2023filed on 07 Jun 2024
- Year ended 31 Dec 2022filed on 22 Feb 2024
- Year ended 31 Dec 2021filed on 30 May 2022
Belderm's financial analysis
- Solvency-1368.5%sector median: 32.3%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Belderm
Belderm's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0543.789.522
- VAT number
- BE0543789522
- Peppol
- Registered · 0208:0543789522 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 06 Jan 2014
- Registered office
- 1200 Woluwe-Saint-Lambert
- Latest accounts
- 2025 · filed on 07 Aug 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Belderm (SRL) has been based in Woluwe-Saint-Lambert since 2014, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 3,911 € and equity of −99,893 €; its revenue is not published. Its solvency stands at -1368.5%, below the median of its sector (32.3%).
Companies similar to Belderm
Companies in the same business, of comparable size and area, outside its group.
- Cirba Wholesale of pharmaceutical and medical goods Ixelles · balance sheet 67,062 €
- Eole S.A .(Eolemed ET/OU Testeol) Wholesale of pharmaceutical and medical goods Uccle · balance sheet 3,164 €
- LE Vinh Pharma Activities of agents involved in non-specialised wholesale Wavre · balance sheet 24,139 €
- IBSA Pharma Wholesale of pharmaceutical and medical goods Brussels · balance sheet 71,733 €
- Enzo Life Sciences Wholesale of pharmaceutical and medical goods Ixelles · balance sheet 142,693 €
- Linden API Wholesale of pharmaceutical and medical goods Ixelles · balance sheet 12,520 €
- AlphaCare Wholesale of pharmaceutical and medical goods Grez-Doiceau · balance sheet 559,557 €
- Mark Schneider Wholesale of pharmaceutical and medical goods Etterbeek · balance sheet 113,169 €
Frequently asked questions about Belderm
What is the revenue of Belderm?
Belderm files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Belderm?
In Belgium, the VAT number is the company number prefixed with BE: BE0543789522 for Belderm, if the company is VAT-registered. Its company number (CBE) is 0543.789.522.
Where is the registered office of Belderm?
According to the CBE register, the registered office of Belderm is in 1200 Woluwe-Saint-Lambert.
What is the equity of Belderm?
At the close of the 2025 financial year, the equity of Belderm amounts to -99,893 €, a solvency of -1368.5% of total assets.
Who manages Belderm?
The register lists 3 active mandates at Belderm. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Belderm
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →